Selling Your Healthcare or Life Sciences Company and avoiding common pitfalls

Interest in investing in healthcare services and technology companies is at unprecedented levels.

Supported by enormous reserves of capital, large companies, private equity firms, and family offices are buying medical groups and healthcare companies across the healthcare space.

With this level of interest comes generally higher valuations, but also more pitfalls for sellers.

This whitepaper gives medical groups, life sciences, and healthcare companies in the lower middle market  ($10 to $100 in revenue) an understanding of:

  • Financing and M&A alternatives available
  • The role of financial buyers
  • Key issues around selling equity in your business  
  • The typical financing and M&A process  
  • And more.


get THE
WHITEPAPER

By supplying my contact information, I authorize ShareVault to contact me about relevant content, products, and services. We're committed to your privacy, for more information, check out our  Privacy Policy .

ABOUT SHAREVAULT

ShareVault’s secure document sharing solution gives organizations of all sizes in all industries the confidence to simply and securely share sensitive documents with third parties during due diligence, fundraising, board communications, and any circumstance when it is crucial that confidential information is maintained under the highest level of security and control.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.

guest author:

Company team

John Selig

Managing Partner, WaveEdge Capital

John Selig is a Managing Partner at WaveEdge Capital, a boutique healthcare investment bank based in Silicon Valley. John has over 20 years of experience in healthcare and M&A transactions. He is a former management consultant to healthcare companies and an M&A attorney.

IN COLLABORATION WITH:

Demo Logo